Monday, August 31, 2026

USD/CNH Jumps By 3% In The Last 21 Sessions

USD/CNH Jumps By 3% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 3.13% for the last 21 sessions. At 05:06 EST on Monday, 5 June, USD/CNH (USDCNH) is $7.13.

USD/CNH's yearly highs and lows, it's 0.492% up from its 52-week low and 0.006% down from its 52-week high.

News about

  • Usd/jpy bulls trace firmer yields above 140.00, US pmis, Japan GDP eyed. According to FXStreet on Monday, 5 June, "USD/JPY clings to mild gains around 140.20 as it cheers upbeat Treasury bond yields, as well as the firmer US Dollar to propel the USD/JPY prices. ", "It's worth noting, however, that the hawkish concerns about the Bank of Japan (BoJ) officials and optimism about the US debt ceiling deal, as well as US credit rating, prod the USD/JPY bulls. "
  • Usd/jpy price analysis: ready to fly above 140.40 as upbeat US NFP accelerates hawkish fed bets. According to FXStreet on Monday, 5 June, "The USD/JPY pair has shifted its auction comfortably above the crucial resistance of 140.00 in the Asian session. "

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com